São Paulo medical journal = Revista paulista de medicina
-
Randomized Controlled Trial Comparative Study Clinical Trial
Misoprostol versus oxytocin for labor induction in term and post-term pregnancy: randomized controlled trial.
Misoprostol, a synthetic E1 methyl analog prostaglandin, is at present receiving attention as a cervical modifier and labor induction agent. However, there is still a need for better determination of its safety and effectiveness. ⋯ 25 g of misoprostol used vaginally every 4 hours is safer and more efficient for cervical ripening and labor induction than oxytocin.